CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Disease Registry
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.2.4 Disease Registry Patient Registry Software Market by Type
4.2.4.1 Cardiovascular Registry Market size and forecast, by region
4.2.4.2 Diabetes Registry Market size and forecast, by region
4.2.4.3 Cancer Registry Market size and forecast, by region
4.2.4.4 Rare Disease Registry Market size and forecast, by region
4.2.4.5 Others Market size and forecast, by region
4.3 Health Service Registry
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Product Registry
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.4.4 Product Registry Patient Registry Software Market by Type
4.4.4.1 Medical device Registry Market size and forecast, by region
4.4.4.2 Drug Registry Market size and forecast, by region
CHAPTER 5: PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE
5.1 Overview
5.1.1 Market size and forecast
5.2 Standalone
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Integrated
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
CHAPTER 6: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY
6.1 Overview
6.1.1 Market size and forecast
6.2 Population Health Management
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Health Information Exchange
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Patient Care Management
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Medical Research and Clinical Studies
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
6.6 Others
6.6.1 Key market trends, growth factors and opportunities
6.6.2 Market size and forecast, by region
6.6.3 Market analysis by country
CHAPTER 7: PATIENT REGISTRY SOFTWARE MARKET, BY END USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Hospitals
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Government and third party organizations
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Pharma, Biotech and Medical Device Companies
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country
7.5 Others
7.5.1 Key market trends, growth factors and opportunities
7.5.2 Market size and forecast, by region
7.5.3 Market analysis by country
CHAPTER 8: PATIENT REGISTRY SOFTWARE MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Registry type
8.2.2.1 North America Disease Registry Patient Registry Software Market by Type
8.2.2.2 North America Product Registry Patient Registry Software Market by Type
8.2.3 North America Market size and forecast, by Software type
8.2.4 North America Market size and forecast, by Functionality
8.2.5 North America Market size and forecast, by End User
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Registry type
8.2.6.1.2 Market size and forecast, by Software type
8.2.6.1.3 Market size and forecast, by Functionality
8.2.6.1.4 Market size and forecast, by End User
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Registry type
8.2.6.2.2 Market size and forecast, by Software type
8.2.6.2.3 Market size and forecast, by Functionality
8.2.6.2.4 Market size and forecast, by End User
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Registry type
8.2.6.3.2 Market size and forecast, by Software type
8.2.6.3.3 Market size and forecast, by Functionality
8.2.6.3.4 Market size and forecast, by End User
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Registry type
8.3.2.1 Europe Disease Registry Patient Registry Software Market by Type
8.3.2.2 Europe Product Registry Patient Registry Software Market by Type
8.3.3 Europe Market size and forecast, by Software type
8.3.4 Europe Market size and forecast, by Functionality
8.3.5 Europe Market size and forecast, by End User
8.3.6 Europe Market size and forecast, by country
8.3.6.1 Germany
8.3.6.1.1 Market size and forecast, by Registry type
8.3.6.1.2 Market size and forecast, by Software type
8.3.6.1.3 Market size and forecast, by Functionality
8.3.6.1.4 Market size and forecast, by End User
8.3.6.2 France
8.3.6.2.1 Market size and forecast, by Registry type
8.3.6.2.2 Market size and forecast, by Software type
8.3.6.2.3 Market size and forecast, by Functionality
8.3.6.2.4 Market size and forecast, by End User
8.3.6.3 UK
8.3.6.3.1 Market size and forecast, by Registry type
8.3.6.3.2 Market size and forecast, by Software type
8.3.6.3.3 Market size and forecast, by Functionality
8.3.6.3.4 Market size and forecast, by End User
8.3.6.4 Italy
8.3.6.4.1 Market size and forecast, by Registry type
8.3.6.4.2 Market size and forecast, by Software type
8.3.6.4.3 Market size and forecast, by Functionality
8.3.6.4.4 Market size and forecast, by End User
8.3.6.5 Spain
8.3.6.5.1 Market size and forecast, by Registry type
8.3.6.5.2 Market size and forecast, by Software type
8.3.6.5.3 Market size and forecast, by Functionality
8.3.6.5.4 Market size and forecast, by End User
8.3.6.6 Rest of Europe
8.3.6.6.1 Market size and forecast, by Registry type
8.3.6.6.2 Market size and forecast, by Software type
8.3.6.6.3 Market size and forecast, by Functionality
8.3.6.6.4 Market size and forecast, by End User
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Registry type
8.4.2.1 Asia-Pacific Disease Registry Patient Registry Software Market by Type
8.4.2.2 Asia-Pacific Product Registry Patient Registry Software Market by Type
8.4.3 Asia-Pacific Market size and forecast, by Software type
8.4.4 Asia-Pacific Market size and forecast, by Functionality
8.4.5 Asia-Pacific Market size and forecast, by End User
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 Japan
8.4.6.1.1 Market size and forecast, by Registry type
8.4.6.1.2 Market size and forecast, by Software type
8.4.6.1.3 Market size and forecast, by Functionality
8.4.6.1.4 Market size and forecast, by End User
8.4.6.2 China
8.4.6.2.1 Market size and forecast, by Registry type
8.4.6.2.2 Market size and forecast, by Software type
8.4.6.2.3 Market size and forecast, by Functionality
8.4.6.2.4 Market size and forecast, by End User
8.4.6.3 Australia
8.4.6.3.1 Market size and forecast, by Registry type
8.4.6.3.2 Market size and forecast, by Software type
8.4.6.3.3 Market size and forecast, by Functionality
8.4.6.3.4 Market size and forecast, by End User
8.4.6.4 India
8.4.6.4.1 Market size and forecast, by Registry type
8.4.6.4.2 Market size and forecast, by Software type
8.4.6.4.3 Market size and forecast, by Functionality
8.4.6.4.4 Market size and forecast, by End User
8.4.6.5 South Korea
8.4.6.5.1 Market size and forecast, by Registry type
8.4.6.5.2 Market size and forecast, by Software type
8.4.6.5.3 Market size and forecast, by Functionality
8.4.6.5.4 Market size and forecast, by End User
8.4.6.6 Rest of Asia-Pacific
8.4.6.6.1 Market size and forecast, by Registry type
8.4.6.6.2 Market size and forecast, by Software type
8.4.6.6.3 Market size and forecast, by Functionality
8.4.6.6.4 Market size and forecast, by End User
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Registry type
8.5.2.1 LAMEA Disease Registry Patient Registry Software Market by Type
8.5.2.2 LAMEA Product Registry Patient Registry Software Market by Type
8.5.3 LAMEA Market size and forecast, by Software type
8.5.4 LAMEA Market size and forecast, by Functionality
8.5.5 LAMEA Market size and forecast, by End User
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Brazil
8.5.6.1.1 Market size and forecast, by Registry type
8.5.6.1.2 Market size and forecast, by Software type
8.5.6.1.3 Market size and forecast, by Functionality
8.5.6.1.4 Market size and forecast, by End User
8.5.6.2 Saudi Arabia
8.5.6.2.1 Market size and forecast, by Registry type
8.5.6.2.2 Market size and forecast, by Software type
8.5.6.2.3 Market size and forecast, by Functionality
8.5.6.2.4 Market size and forecast, by End User
8.5.6.3 South Africa
8.5.6.3.1 Market size and forecast, by Registry type
8.5.6.3.2 Market size and forecast, by Software type
8.5.6.3.3 Market size and forecast, by Functionality
8.5.6.3.4 Market size and forecast, by End User
8.5.6.4 Rest of LAMEA
8.5.6.4.1 Market size and forecast, by Registry type
8.5.6.4.2 Market size and forecast, by Software type
8.5.6.4.3 Market size and forecast, by Functionality
8.5.6.4.4 Market size and forecast, by End User
CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments
CHAPTER 10: COMPANY PROFILES
10.1 Conduent, Inc.
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 Dacima Software Inc.
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Elekta AB (pub)
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 FIGmd, Inc.
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 IBM Corp
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 ImageTrend, Inc.
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 IQVIA Holdings
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 McKesson Corporation
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 OpenText Corporation
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 Optum, Inc.
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments
10.11 Ordinal Data, Inc.
10.11.1 Company overview
10.11.2 Company snapshot
10.11.3 Operating business segments
10.11.4 Product portfolio
10.11.5 Business performance
10.11.6 Key strategic moves and developments
10.12 Premier, Inc.
10.12.1 Company overview
10.12.2 Company snapshot
10.12.3 Operating business segments
10.12.4 Product portfolio
10.12.5 Business performance
10.12.6 Key strategic moves and developments
TABLE 1. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
TABLE 2. PATIENT REGISTRY SOFTWARE MARKET, FOR DISEASE REGISTRY, BY REGION, 2021-2031 ($MILLION)
TABLE 3. PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. GLOBAL DISEASE REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 5. PATIENT REGISTRY SOFTWARE MARKET, FOR CARDIOVASCULAR REGISTRY, BY REGION, 2021-2031 ($MILLION)
TABLE 6. PATIENT REGISTRY SOFTWARE MARKET, FOR DIABETES REGISTRY, BY REGION, 2021-2031 ($MILLION)
TABLE 7. PATIENT REGISTRY SOFTWARE MARKET, FOR CANCER REGISTRY, BY REGION, 2021-2031 ($MILLION)
TABLE 8. PATIENT REGISTRY SOFTWARE MARKET, FOR RARE DISEASE REGISTRY, BY REGION, 2021-2031 ($MILLION)
TABLE 9. PATIENT REGISTRY SOFTWARE MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 10. PATIENT REGISTRY SOFTWARE MARKET, FOR HEALTH SERVICE REGISTRY, BY REGION, 2021-2031 ($MILLION)
TABLE 11. PATIENT REGISTRY SOFTWARE MARKET FOR HEALTH SERVICE REGISTRY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 12. PATIENT REGISTRY SOFTWARE MARKET, FOR PRODUCT REGISTRY, BY REGION, 2021-2031 ($MILLION)
TABLE 13. PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 14. GLOBAL PRODUCT REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 15. PATIENT REGISTRY SOFTWARE MARKET, FOR MEDICAL DEVICE REGISTRY, BY REGION, 2021-2031 ($MILLION)
TABLE 16. PATIENT REGISTRY SOFTWARE MARKET, FOR DRUG REGISTRY, BY REGION, 2021-2031 ($MILLION)
TABLE 17. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
TABLE 18. PATIENT REGISTRY SOFTWARE MARKET, FOR STANDALONE, BY REGION, 2021-2031 ($MILLION)
TABLE 19. PATIENT REGISTRY SOFTWARE MARKET FOR STANDALONE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 20. PATIENT REGISTRY SOFTWARE MARKET, FOR INTEGRATED, BY REGION, 2021-2031 ($MILLION)
TABLE 21. PATIENT REGISTRY SOFTWARE MARKET FOR INTEGRATED, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 22. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
TABLE 23. PATIENT REGISTRY SOFTWARE MARKET, FOR POPULATION HEALTH MANAGEMENT, BY REGION, 2021-2031 ($MILLION)
TABLE 24. PATIENT REGISTRY SOFTWARE MARKET FOR POPULATION HEALTH MANAGEMENT, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 25. PATIENT REGISTRY SOFTWARE MARKET, FOR HEALTH INFORMATION EXCHANGE, BY REGION, 2021-2031 ($MILLION)
TABLE 26. PATIENT REGISTRY SOFTWARE MARKET FOR HEALTH INFORMATION EXCHANGE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 27. PATIENT REGISTRY SOFTWARE MARKET, FOR PATIENT CARE MANAGEMENT, BY REGION, 2021-2031 ($MILLION)
TABLE 28. PATIENT REGISTRY SOFTWARE MARKET FOR PATIENT CARE MANAGEMENT, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 29. PATIENT REGISTRY SOFTWARE MARKET, FOR MEDICAL RESEARCH AND CLINICAL STUDIES, BY REGION, 2021-2031 ($MILLION)
TABLE 30. PATIENT REGISTRY SOFTWARE MARKET FOR MEDICAL RESEARCH AND CLINICAL STUDIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 31. PATIENT REGISTRY SOFTWARE MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 32. PATIENT REGISTRY SOFTWARE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 33. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 34. PATIENT REGISTRY SOFTWARE MARKET, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
TABLE 35. PATIENT REGISTRY SOFTWARE MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 36. PATIENT REGISTRY SOFTWARE MARKET, FOR GOVERNMENT AND THIRD PARTY ORGANIZATIONS, BY REGION, 2021-2031 ($MILLION)
TABLE 37. PATIENT REGISTRY SOFTWARE MARKET FOR GOVERNMENT AND THIRD PARTY ORGANIZATIONS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 38. PATIENT REGISTRY SOFTWARE MARKET, FOR PHARMA, BIOTECH AND MEDICAL DEVICE COMPANIES, BY REGION, 2021-2031 ($MILLION)
TABLE 39. PATIENT REGISTRY SOFTWARE MARKET FOR PHARMA, BIOTECH AND MEDICAL DEVICE COMPANIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 40. PATIENT REGISTRY SOFTWARE MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 41. PATIENT REGISTRY SOFTWARE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 42. PATIENT REGISTRY SOFTWARE MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 43. NORTH AMERICA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
TABLE 44. NORTH AMERICA DISEASE REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 45. NORTH AMERICA PRODUCT REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 46. NORTH AMERICA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
TABLE 47. NORTH AMERICA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
TABLE 48. NORTH AMERICA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 49. NORTH AMERICA PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 50. U.S. PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
TABLE 51. U.S. PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
TABLE 52. U.S. PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
TABLE 53. U.S. PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 54. CANADA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
TABLE 55. CANADA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
TABLE 56. CANADA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
TABLE 57. CANADA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 58. MEXICO PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
TABLE 59. MEXICO PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
TABLE 60. MEXICO PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
TABLE 61. MEXICO PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 62. EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
TABLE 63. EUROPE DISEASE REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 64. EUROPE PRODUCT REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 65. EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
TABLE 66. EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
TABLE 67. EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 68. EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 69. GERMANY PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
TABLE 70. GERMANY PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
TABLE 71. GERMANY PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
TABLE 72. GERMANY PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 73. FRANCE PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
TABLE 74. FRANCE PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
TABLE 75. FRANCE PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
TABLE 76. FRANCE PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 77. UK PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
TABLE 78. UK PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
TABLE 79. UK PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
TABLE 80. UK PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 81. ITALY PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
TABLE 82. ITALY PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
TABLE 83. ITALY PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
TABLE 84. ITALY PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 85. SPAIN PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
TABLE 86. SPAIN PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
TABLE 87. SPAIN PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
TABLE 88. SPAIN PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 89. REST OF EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
TABLE 90. REST OF EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
TABLE 91. REST OF EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
TABLE 92. REST OF EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 93. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
TABLE 94. ASIA-PACIFIC DISEASE REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 95. ASIA-PACIFIC PRODUCT REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 96. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
TABLE 97. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
TABLE 98. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 99. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 100. JAPAN PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
TABLE 101. JAPAN PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
TABLE 102. JAPAN PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
TABLE 103. JAPAN PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 104. CHINA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
TABLE 105. CHINA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
TABLE 106. CHINA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
TABLE 107. CHINA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 108. AUSTRALIA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
TABLE 109. AUSTRALIA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
TABLE 110. AUSTRALIA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
TABLE 111. AUSTRALIA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 112. INDIA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
TABLE 113. INDIA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
TABLE 114. INDIA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
TABLE 115. INDIA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 116. SOUTH KOREA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
TABLE 117. SOUTH KOREA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
TABLE 118. SOUTH KOREA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
TABLE 119. SOUTH KOREA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 120. REST OF ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
TABLE 121. REST OF ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
TABLE 122. REST OF ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
TABLE 123. REST OF ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 124. LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
TABLE 125. LAMEA DISEASE REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 126. LAMEA PRODUCT REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 127. LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
TABLE 128. LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
TABLE 129. LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 130. LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 131. BRAZIL PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
TABLE 132. BRAZIL PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
TABLE 133. BRAZIL PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
TABLE 134. BRAZIL PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 135. SAUDI ARABIA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
TABLE 136. SAUDI ARABIA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
TABLE 137. SAUDI ARABIA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
TABLE 138. SAUDI ARABIA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 139. SOUTH AFRICA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
TABLE 140. SOUTH AFRICA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
TABLE 141. SOUTH AFRICA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
TABLE 142. SOUTH AFRICA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 143. REST OF LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
TABLE 144. REST OF LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
TABLE 145. REST OF LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
TABLE 146. REST OF LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 147.CONDUENT, INC.: COMPANY SNAPSHOT
TABLE 148.CONDUENT, INC.: OPERATING SEGMENTS
TABLE 149.CONDUENT, INC.: PRODUCT PORTFOLIO
TABLE 150.CONDUENT, INC.: NET SALES,
TABLE 151.CONDUENT, INC.: KEY STRATERGIES
TABLE 152.DACIMA SOFTWARE INC.: COMPANY SNAPSHOT
TABLE 153.DACIMA SOFTWARE INC.: OPERATING SEGMENTS
TABLE 154.DACIMA SOFTWARE INC.: PRODUCT PORTFOLIO
TABLE 155.DACIMA SOFTWARE INC.: NET SALES,
TABLE 156.DACIMA SOFTWARE INC.: KEY STRATERGIES
TABLE 157.ELEKTA AB (PUB): COMPANY SNAPSHOT
TABLE 158.ELEKTA AB (PUB): OPERATING SEGMENTS
TABLE 159.ELEKTA AB (PUB): PRODUCT PORTFOLIO
TABLE 160.ELEKTA AB (PUB): NET SALES,
TABLE 161.ELEKTA AB (PUB): KEY STRATERGIES
TABLE 162.FIGMD, INC.: COMPANY SNAPSHOT
TABLE 163.FIGMD, INC.: OPERATING SEGMENTS
TABLE 164.FIGMD, INC.: PRODUCT PORTFOLIO
TABLE 165.FIGMD, INC.: NET SALES,
TABLE 166.FIGMD, INC.: KEY STRATERGIES
TABLE 167.IBM CORP: COMPANY SNAPSHOT
TABLE 168.IBM CORP: OPERATING SEGMENTS
TABLE 169.IBM CORP: PRODUCT PORTFOLIO
TABLE 170.IBM CORP: NET SALES,
TABLE 171.IBM CORP: KEY STRATERGIES
TABLE 172.IMAGETREND, INC.: COMPANY SNAPSHOT
TABLE 173.IMAGETREND, INC.: OPERATING SEGMENTS
TABLE 174.IMAGETREND, INC.: PRODUCT PORTFOLIO
TABLE 175.IMAGETREND, INC.: NET SALES,
TABLE 176.IMAGETREND, INC.: KEY STRATERGIES
TABLE 177.IQVIA HOLDINGS: COMPANY SNAPSHOT
TABLE 178.IQVIA HOLDINGS: OPERATING SEGMENTS
TABLE 179.IQVIA HOLDINGS: PRODUCT PORTFOLIO
TABLE 180.IQVIA HOLDINGS: NET SALES,
TABLE 181.IQVIA HOLDINGS: KEY STRATERGIES
TABLE 182.MCKESSON CORPORATION: COMPANY SNAPSHOT
TABLE 183.MCKESSON CORPORATION: OPERATING SEGMENTS
TABLE 184.MCKESSON CORPORATION: PRODUCT PORTFOLIO
TABLE 185.MCKESSON CORPORATION: NET SALES,
TABLE 186.MCKESSON CORPORATION: KEY STRATERGIES
TABLE 187.OPENTEXT CORPORATION: COMPANY SNAPSHOT
TABLE 188.OPENTEXT CORPORATION: OPERATING SEGMENTS
TABLE 189.OPENTEXT CORPORATION: PRODUCT PORTFOLIO
TABLE 190.OPENTEXT CORPORATION: NET SALES,
TABLE 191.OPENTEXT CORPORATION: KEY STRATERGIES
TABLE 192.OPTUM, INC.: COMPANY SNAPSHOT
TABLE 193.OPTUM, INC.: OPERATING SEGMENTS
TABLE 194.OPTUM, INC.: PRODUCT PORTFOLIO
TABLE 195.OPTUM, INC.: NET SALES,
TABLE 196.OPTUM, INC.: KEY STRATERGIES
TABLE 197.ORDINAL DATA, INC.: COMPANY SNAPSHOT
TABLE 198.ORDINAL DATA, INC.: OPERATING SEGMENTS
TABLE 199.ORDINAL DATA, INC.: PRODUCT PORTFOLIO
TABLE 200.ORDINAL DATA, INC.: NET SALES,
TABLE 201.ORDINAL DATA, INC.: KEY STRATERGIES
TABLE 202.PREMIER, INC.: COMPANY SNAPSHOT
TABLE 203.PREMIER, INC.: OPERATING SEGMENTS
TABLE 204.PREMIER, INC.: PRODUCT PORTFOLIO
TABLE 205.PREMIER, INC.: NET SALES,
TABLE 206.PREMIER, INC.: KEY STRATERGIES
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
